Quantora — Markets, Analysis & Valuation

Valuations are estimates only, produced by transparent models for education and research. This is not financial advice. Verify before trading.

Thermo Fisher Scientific Inc — Valuation Dashboard

Download PDF report Company page

MARKET PRICE

461.69

DCF (FCFF)

98.30

-78.71% vs market

COMPARABLES

n/a

DIVIDEND (DDM)

n/a

ASSET-BASED

n/a

QUALITY SCORE

…

Implied values per model vs market — models disagree by design; each makes different assumptions. Estimates only.

Composite signal

Watch

Health Care · sig-v0.1 · confidence 75/100

Value

Quality

Momentum

Low-vol

Composite 34 (7th percentile in Health Care)

MOS

Value

Band

Trend

The model flags: MOS -380.8% vs 40% needed [fail] · relative value [fail] · composite 7 pct, band out [fail] · trend unconfirmed [fail]. Confidence 75/100.

Educational model classification — not a buy/sell recommendation, and not personalised. Verify before trading.

As of 2026-06-17 06:00 UTC.

Assumptions

Year-1 revenue growth %

Terminal growth %

Target operating margin %

Tax rate %

WACC override % (blank = CAPM)

Defaults derive from the company's statements; risk-free rate source: FRED:DGS10 (4.43 %). Any change is recorded as a user override in the audit trail.

Inputs from statements

Revenue (latest FY)	44.56B
Operating margin	17.4 %
Net debt	29.32B
Diluted shares	378.00M
Beta	1.00 (default)
Market price	461.69

Fundamentals as of 2025-12-31 · Source: DEMO

INTRINSIC VALUE / SHARE

98.30

MARKET PRICE

461.69

UPSIDE

-78.71%

MARGIN OF SAFETY

-369.7 %

Enterprise value 66.48B · Equity value 37.16B · WACC 8.37 % · Formula v1.0 · Audit run 9781227e

No beta available — defaulting to 1.0.

Bull/base/bear scenarios, sensitivity tables and the comparable / dividend / asset-based models require the Pro tier — the DCF summary above is included in Free. (Billing integration pending; tiers live in the subscriptions table.)